There is now evidence from multiple Phase II clinical trials that psychedelic drugs can exert long-lasting anxiolytic, anti-depressant, and anti-drug abuse (nicotine and ethanol) effects in patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback